Q1 FY27 results: PAT up 26 percent consolidated, 42 percent standalone
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts less than Nifty Microcap 250 and 2.1 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Metropolis Healthcare Q1 FY27: consolidated revenue Rs 4,502 million, up about 16.6 percent year on year, with profit after tax of Rs 569 million, up 25.7 percent. Standalone revenue grew 15.2 percent to Rs 3,723 million and PAT rose 42 percent to Rs 506 million. Auditors issued an unmodified limited review. Board noted transfer of External Quality Assessment Services business to a wholly owned subsidiary will take two more months than originally planned.
Strong Q1 with consolidated profit growth near 26 percent; clean auditor review and delayed subsidiary transfer are minor items to watch.